Shoulder Options seeks to divest its AFT™ Proximal Humerus Fracture, AFT™ Greater Tuberosity Fracture and CRP™ Cuff Repair plates.
The FDA-cleared systems have been granted U.S. utility and design patents, and the portfolio includes what is reported to be the first device designed specifically for treatment of greater tuberosity fractures of the proximal humerus bone, as well as the first fixable suture anchor plate on the market.
Additional details for the systems are available online.
Shoulder Options seeks to divest its AFT™ Proximal Humerus Fracture, AFT™ Greater Tuberosity Fracture and CRP™ Cuff Repair plates.
The FDA-cleared systems have been granted U.S. utility and design patents, and the portfolio includes what is reported to be the first device designed specifically for treatment of greater...
Shoulder Options seeks to divest its AFT™ Proximal Humerus Fracture, AFT™ Greater Tuberosity Fracture and CRP™ Cuff Repair plates.
The FDA-cleared systems have been granted U.S. utility and design patents, and the portfolio includes what is reported to be the first device designed specifically for treatment of greater tuberosity fractures of the proximal humerus bone, as well as the first fixable suture anchor plate on the market.
Additional details for the systems are available online.
Copy to clipboard 
